Alyeska Investment Group’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.48M | Buy |
4,459,087
+295,353
| +7% | +$363K | 0.02% | 411 |
|
|
2025
Q1 | $4.58M | Sell |
4,163,734
-4,644,780
| -53% | -$5.11M | 0.02% | 365 |
|
|
2024
Q4 | $7.97M | Buy |
8,808,514
+3,041,058
| +53% | +$2.75M | 0.03% | 361 |
|
|
2024
Q3 | $5.69M | Buy |
5,767,456
+279,940
| +5% | +$276K | 0.03% | 339 |
|
|
2024
Q2 | $4.94M | Buy |
+5,487,516
| New | +$4.94M | 0.03% | 337 |
|
|
2024
Q1 | – | Sell |
-2,913,216
| Closed | -$2.66M | – | 503 |
|
|
2023
Q4 | $2.66M | Sell |
2,913,216
-3,890,284
| -57% | -$3.55M | 0.02% | 335 |
|
|
2023
Q3 | $5.67M | Buy |
+6,803,500
| New | +$5.67M | 0.04% | 325 |
|
|
2022
Q3 | – | Sell |
-114,608
| Closed | -$959K | – | 419 |
|
|
2022
Q2 | $959K | Sell |
114,608
-50,000
| -30% | -$418K | 0.01% | 499 |
|
|
2022
Q1 | $1.43M | Buy |
+164,608
| New | +$1.43M | 0.02% | 473 |
|
|
2021
Q4 | – | Sell |
-120,066
| Closed | -$1.51M | – | 659 |
|
|
2021
Q3 | $1.51M | Sell |
120,066
-650,000
| -84% | -$8.17M | 0.02% | 539 |
|
|
2021
Q2 | $6.25M | Buy |
770,066
+50,000
| +7% | +$406K | 0.07% | 296 |
|
|
2021
Q1 | $6.66M | Buy |
720,066
+182,426
| +34% | +$1.69M | 0.09% | 265 |
|
|
2020
Q4 | $5.2M | Sell |
537,640
-635,661
| -54% | -$6.15M | 0.07% | 262 |
|
|
2020
Q3 | $14.6M | Sell |
1,173,301
-321,321
| -21% | -$3.99M | 0.22% | 143 |
|
|
2020
Q2 | $19.4M | Buy |
1,494,622
+1,017,784
| +213% | +$13.2M | 0.29% | 125 |
|
|
2020
Q1 | $4.84M | Buy |
476,838
+98,902
| +26% | +$1M | 0.1% | 188 |
|
|
2019
Q4 | $5.91M | Buy |
377,936
+358,663
| +1,861% | +$5.61M | 0.08% | 206 |
|
|
2019
Q3 | $324K | Sell |
19,273
-82,591
| -81% | -$1.39M | ﹤0.01% | 336 |
|
|
2019
Q2 | $2.26M | Sell |
101,864
-50,619
| -33% | -$1.12M | 0.03% | 288 |
|
|
2019
Q1 | $3.3M | Buy |
+152,483
| New | +$3.3M | 0.04% | 227 |
|